CDKL5
protein-codingcyclin dependent kinase like 5, the group of Cyclin dependent kinases|Cilia and flagella associated
Gene summary
This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
- STK9
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~228.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0100039
Submitter: ClinGen
The CDKL5 gene is associated with CDKL5 disorder, a disorder sometimes referred to as a Rett syndrome variant, but which can be considered a distinct condition. Individuals with CDKL5 disorder lack some of the distinctive clinical features of classical Rett syndrome such as the clear period of regression and the characteristic intense eye-gaze (PMID:21154482). Of note, normal development during the first 6 months of life commonly seen in Rett syndrome is rare in individuals with CDKL5 disorder. Heterozygous truncating as well as missense variants of CDKL5 cause CDKL5 disorder, almost exclusively arising de novo. Two mouse models of CDKL5 disorder have been characterized (Wang 2012, Amendola 2014), which recaputulate many of the autism-associated phenotypes of CDKL5 disorder. Notably, however, neither mouse model exhibited spontaneous seizures, challenging the usefulness of Cdkl5 KO mice in modeling the human phenotype. Most mice studied have also been hemizygous males, while CDKL5 disorder primarily affects heterozygous females. In summary, CDKL5 is definitively associated with CDKL5 disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Approved by the ClinGen Rett/Angelman Expert Panel 4/30/2018.
Inheritance Pattern: XL
Disease ID:MONDO:0010396
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0000088
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0010396
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0017746
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100062
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010396
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010396
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: As with other conditions involving seizures, optimal seizure control is beneficial, and awareness of genetic causes may help with medication selection
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CDKL5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001323289.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 30 | 173 | 10 | 216 |
| missense | 42 | 95 | 398 | 68 | 25 | 628 |
| nonsense | 79 | 22 | 7 | 108 | ||
| start loss | 1 | 1 | ||||
| frameshift | 190 | 78 | 268 | |||
| splice donor/acceptor (+/-2bp) | 44 | 31 | 18 | 93 | ||
| Total | 357 | 227 | 454 | 241 | 35 | 1314 |
Highest pathogenic variant AF is 0.000003642178
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001310218.1 | 17 | MANE Select | |
| Ensembl | ENSP00000485244.1 | 17 | MANE Select | |
| RefSeq | NP_001032420.1 | 20 | Standard | |
| RefSeq | NP_003150.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Brain-Derived Neurotrophic Factor (BDNF) signaling pathway
Biological Process
- neuron migration
- protein phosphorylation
- positive regulation of GTPase activity
- positive regulation of axon extension
- protein autophosphorylation
Molecular Function
- protein kinase activity
- protein serine/threonine kinase activity
- cyclin-dependent protein serine/threonine kinase activity
- ATP binding
- kinase activity
Cellular Component
- nucleus
- nucleoplasm
- centrosome
- cytosol
- ruffle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000379989
- Coding exons
- 20
- Length
- 228047
- Individuals with no LoFs
- 125721
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 1
- Defined
- 125723
- p
- 0.00000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.74 | 246 | 400 | 0.615 | 0.0000323 | 6774 |
| Missense (PolyPhen) | 14 | 44.31 | 0.31596 | 662 | ||
| Synonymous | -0.498 | 157 | 149 | 1.05 | 0.0000121 | 1987 |
| Loss of Function | 4.95 | 3 | 34.3 | 0.0875 | 0.00000261 | 613 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000024 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175). {ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:29420175}.;
- Disease
- DISEASE: Note=Chromosomal aberrations involving CDKL5 are found in patients manifesting early-onset seizures and spams and psychomotor impairment. Translocation t(X;6)(p22.3;q14); translocation t(X;7)(p22.3;p15).; DISEASE: Epileptic encephalopathy, early infantile, 2 (EIEE2) [MIM:300672]: A severe form of epilepsy characterized by seizures or spasms beginning in infancy. Patients with epileptic encephalopathy early infantile type 2 manifest features resembling Rett syndrome such as microcephaly, lack of speech development, stereotypic hand movements. However, EIEE2 and Rett syndrome are considered two distinct entities. {ECO:0000269|PubMed:12736870, ECO:0000269|PubMed:15492925, ECO:0000269|PubMed:15499549, ECO:0000269|PubMed:15689447, ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16015284, ECO:0000269|PubMed:16611748, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:17993579, ECO:0000269|PubMed:18790821, ECO:0000269|PubMed:18809835, ECO:0000269|PubMed:19241098, ECO:0000269|PubMed:19253388, ECO:0000269|PubMed:23662938, ECO:0000269|PubMed:23708187, ECO:0000269|PubMed:24564546, ECO:0000269|PubMed:26993267, ECO:0000269|PubMed:27864847}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.128
- RVIS EVS
- -0.67
- RVIS percentile EVS
- 15.86
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.924
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |